RNA expression profiling in lymphoblastoid cell lines from mutated and non‐mutated amyotrophic lateral sclerosis patients
The Journal of Gene Medicine · 2024
DOI: 10.1002/jgm.3711 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Gene Medicine, 2024. Verfasst von Jessica Garau und 9 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Mondino Foundation, Pavia, Italy. Hauptthemen laut MEDLINE: Amyotrophic Lateral Sclerosis, Gene Expression Profiling, Mutation, Transcriptome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Ministero della Salute, Italian Agency for Research on ALS-ARiSLA, Italian Ministry of Health.
Abstract (Originalsprache)
Background
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by the death of upper and lower motor neurons with an unknown etiology. The difficulty of recovering biological material from patients led to employ lymphoblastoid cell lines (LCLs) as a model for ALS because many pathways, typically located in neurons, are also activated in these cells.
Methods
To investigate the expression of coding and long non‐coding RNAs in LCLs, a transcriptomic profiling of sporadic ALS (SALS) and mutated patients ( FUS , TARDBP , C9ORF72 and SOD1 ) and matched controls was realized. Thus, differentially expressed genes (DEGs) were investigated among the different subgroups of patients. Peripheral blood mononuclear cells (PBMCs) were isolated and immortalized into LCLs via Epstein–Barr virus infection; RNA was extracted, and RNA‐sequencing analysis was performed.
Results
Gene expression profiles of LCLs were genetic‐background‐specific; indeed, only 12 genes were commonly deregulated in all groups. Nonetheless, pathways enriched by DEGs in each group were also compared, and a total of 89 Kyoto Encyclopedia of Genes and Genomes (KEGG) terms were shared among all patients. Eventually, the similarity of affected pathways was also assessed when our data were matched with a transcriptomic profile realized in the PBMCs of the same patients.
Conclusions
We conclude that LCLs are a good model for the study of RNA deregulation in ALS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Mondino Foundation, Pavia, Italy.
- Department of Biology and Biotechnology "L. Spallanzani, University of Pavia, Pavia, Italy.
- Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.
- EnGenome SRL, Pavia, Italy.
Förderung
- Ministero della Salute
- Italian Agency for Research on ALS-ARiSLA
- Italian Ministry of Health
Zitieren
APA
Garau, J., Garofalo, M., Dragoni, F., Scarian, E., Di Gerlando, R., Diamanti, L., Zucca, S., Bordoni, M., Pansarasa, O., & Gagliardi, S. (2024). RNA expression profiling in lymphoblastoid cell lines from mutated and non‐mutated amyotrophic lateral sclerosis patients. The Journal of Gene Medicine. https://doi.org/10.1002/jgm.3711
Vancouver
Garau J, Garofalo M, Dragoni F, Scarian E, Di Gerlando R, Diamanti L, et al. RNA expression profiling in lymphoblastoid cell lines from mutated and non‐mutated amyotrophic lateral sclerosis patients. The Journal of Gene Medicine. 2024. doi:10.1002/jgm.3711
BibTeX
@article{Garau2024,
author = {Garau, Jessica and Garofalo, Maria and Dragoni, Francesca and Scarian, Eveljn and Di Gerlando, Rosalinda and Diamanti, Luca and Zucca, Susanna and Bordoni, Matteo and Pansarasa, Orietta and Gagliardi, Stella},
title = {RNA expression profiling in lymphoblastoid cell lines from mutated and non‐mutated amyotrophic lateral sclerosis patients},
journal = {The Journal of Gene Medicine},
year = {2024},
doi = {10.1002/jgm.3711}
}
EUVIMED